ag 1879 has been researched along with Acute Lymphoid Leukemia in 1 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Excerpt | Relevance | Reference |
---|---|---|
"MLL-rearranged acute lymphoblastic leukemia (ALL) in infants is characterized by a poor clinical outcome and resistance to glucocorticoids (for example, prednisone and dexamethasone)." | 1.38 | Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( de Boer, J; Hulleman, E; Pieters, R; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW; Williams, O, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Spijkers-Hagelstein, JA | 1 |
Schneider, P | 1 |
Hulleman, E | 1 |
de Boer, J | 1 |
Williams, O | 1 |
Pieters, R | 1 |
Stam, RW | 1 |
1 other study available for ag 1879 and Acute Lymphoid Leukemia
Article | Year |
---|---|
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr | 2012 |